Stay updated with breaking news from Looking Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Acquisition broadens oncology pipeline with a portfolio of novel T-cell engagers including HPN328 , an investigational delta-like ligand 3 targeting T-cell engager ...
We exchanged our main debtor t preferred sjares and eliminated over 13billion warrants to preferred shares as well....
EDISON, N.J., Feb. 29, 2024 -- Zerify Inc. , a pioneer in cybersecurity specializing in secure video conferencing and endpoint security, is excited to announce the restructuring of our cap table...
Opinion granted based on positive overall survival and event-free survival results from the Phase 3 KEYNOTE-671 trial First opinion to be granted for an anti-PD-1/L1 therapy in resectable non-small...
Approval by European Commission would expand Reblozyl’s indication to include first-line treatment of anemia in adults with MDS in Europe In the pivotal Phase 3 COMMANDS study, Reblozyl nearly...